General
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Drug Safety and Relevant Issues in the Real-World 2024 (Deadline: 25 May 2024)
- Next-Generation Contrast Agents for Medical Imaging (Deadline: 20 June 2024)
- Therapeutic Agents for the Treatment of Tumors in the CNS (Deadline: 25 June 2024)
- Cardiac Electrophysiology and Pharmacology 2024 (Deadline: 25 June 2024)
- The 20th Anniversary of Pharmaceuticals – Recent Advances in Hybridization and Bioconjugation for Drug Discovery (Deadline: 30 June 2024)
- Neurodegenerative Disorders: Computer – Aided Drug Design, Еxperimental Аpproaches and Mechanisms (Deadline: 15 July 2024)
- Advances in Natural Products and Their Derivatives for Metabolic and Chronic Inflammatory Disease Therapy, 2nd Edition (Deadline: 20 July 2024)
- The 20th Anniversary of Pharmaceuticals—New Insights in Medicinal Chemistry of Nitrogen-Containing Compounds (Deadline: 25 July 2024)
- Advances in Pediatric Drug Formulations (Deadline: 31 July 2024)
- Interaction between Nanoparticles and Antibiotics:Against Antimicrobial Resistance (Deadline: 22 August 2024)
- Plant-Based Therapies for Circulatory Disorders (Deadline: 22 August 2024)
- Potential Therapeutic Methods in Reproductive Aging (Deadline: 23 August 2024)
- Advances in Nuclear Medicine (Deadline: 25 August 2024)